What does central nervous system tumor mean?

A central nervous system tumor, usually shortened to CNS tumor, is a tumor of the brain or the spinal cord. Those two organs are the central nervous system. The National Cancer Institute defines it as "a disease in which abnormal cells form in the tissues of the brain and/or spinal cord."

The nerves that branch out to your arms, legs, and organs are the peripheral nervous system. Tumors there carry other names and follow other rules. Brain and spinal cord tumors get grouped together for solid reasons. They sit inside the same hard case of skull and spine. They are bathed in the same cerebrospinal fluid. They sit behind the same blood-brain barrier, a filter that keeps many drugs from reaching them. So they behave alike and are often treated alike.

The first thing to sort out about any CNS tumor is where it began. A primary CNS tumor starts in the brain or the cord. A metastatic one started somewhere else and traveled. NCI puts it plainly: "Tumors that start in the brain are called primary brain tumors," while a metastatic brain tumor "starts in another part of the body and spreads to the brain." That difference sets the treatment. Breast cancer that has spread to the brain is still breast cancer under the microscope. It is treated with breast cancer drugs, not brain cancer drugs.

Primary CNS tumors behave oddly next to other cancers. They "rarely spread to other parts of the body," NCI notes. They can still travel inside the nervous system, including along the cerebrospinal fluid to the leptomeninges, the two innermost membranes wrapping the brain and cord. That pattern has its own name: leptomeningeal carcinomatosis.

Because they so rarely leave the CNS, most primary CNS tumors are not given a stage in the usual sense. There is no stage I through IV the way there is for colon or breast cancer. They get a grade instead. NCI's summary for clinicians lists four World Health Organization grades. Grade 1 covers "lesions with low proliferative potential" that often can be cured by surgery alone. Grade 2 covers tumors that creep into nearby tissue and "recur more frequently." Grade 3 covers "lesions with histological evidence of malignancy," meaning cells that look clearly cancerous. Grade 4 covers tumors that grow fast and are "necrosis prone," meaning parts of the tumor die off as it outgrows its blood supply.

Benign does not mean harmless here, and that is the point most people miss. A benign lump elsewhere can often just be watched. Inside a skull that cannot expand, even a slow tumor takes up room. NCI says benign CNS tumors "grow and press on nearby areas of the brain," and that both kinds "cause signs and symptoms and need treatment." When a tumor presses on a region, "it may stop that part of the brain from working the way it should." Symptoms follow the location, not the grade. They include morning headache, seizures, trouble with vision, hearing, or speech, weakness, and changes in personality, mood, focus, or behavior.

How these tumors are named has also changed. Molecular findings now sit beside the microscope. An IDH mutation matters enough that NCI reports such patients "have significantly longer survival independent of WHO grade or histological subtype." Loss of two chromosome arms, called 1p/19q codeletion, is "a powerful prognostic factor and may predict for response to chemotherapy." Two tumors that look identical under glass can end up with different names and different outlooks once those tests come back.

NCI's clinician summary cites American Cancer Society estimates of 24,820 new cases and 18,330 deaths from brain and other nervous system tumors in the United States in 2025.

If someone you love has been told they have a CNS tumor, two questions get you most of the way. Is it primary or metastatic? And what is the full pathology name, including the grade and any molecular results? The rest of the plan follows from those answers.